Appointment booking for Dr. Carl Goldstein, MD is currently not available.Dr. Carl Goldstein, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Carl Goldstein, MD (he/him) is a Nephrologist in Westfield, NJ with over 19 years of experience. What is your opinion of Dr. Carl Goldstein, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Carl Goldstein, MD has received over $714 which includes payments from the following companies:
$119.74 from Keryx Biopharmaceuticals, Inc.
$106.24 from Astute Medical, Inc.
$97.10 from Takeda Pharmaceuticals America, Inc.
$71.50 from Fresenius USA Marketing, Inc.
$65.73 from Arbor Pharmaceuticals, Inc.
$41.09 from Amgen Inc.
$32.51 from Allergan Inc.
$29.72 from Luitpold Pharmaceuticals Inc
$26.46 from Mallinckrodt LLC
$25.00 from Takeda Pharmaceuticals U.S.A., Inc.
$17.06 from Ironwood Pharmaceuticals, Inc
$15.58 from Avion Pharmaceuticals
$15.07 from Daiichi Sankyo Inc.
$13.76 from FOREST PHARMACEUTICALS, INC.
$13.62 from Janssen Biotech, Inc.
$12.17 from Mallinckrodt Enterprises LLC
$11.29 from Shire North American Group Inc
$0.94 from Retrophin, Inc.
Payments received by Dr. Carl Goldstein, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!